BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Guo YL, Li JJ, Yuan JQ, Qin XW, Zheng X, Mu CW, Hua YH. Profound thrombocytopenia induced by clopidogrel with a prior history of long-term safe administration. World J Cardiol 2010; 2(6): 160-162 [PMID: 21160734 DOI: 10.4330/wjc.v2.i6.160]
URL: https://www.wjgnet.com/1949-8462/full/v2/i6/160.htm
Number Citing Articles
1
Michele Schiariti, Patrizia Saladini, Domenico Cuturello, Loredana Iannetta, Concetta Torromeo, Paolo Emilio Puddu. Reprint of “Decline in platelet count and long-term post-PCI ischemic events: Implication of the intra-aortic balloon pump”Vascular Pharmacology 2014; 61(1): 35 doi: 10.1016/j.vph.2014.03.003
2
Marianne Skals, Anne-Sofie Greve, Steen K. Fagerberg, Nanna Johnsen, Mette G. Christensen, Helle A. Praetorius. P2X1 receptor blockers reduce the number of circulating thrombocytes and the overall survival of urosepsis with haemolysin-producing Escherichia coliPurinergic Signalling 2019; 15(2): 265 doi: 10.1007/s11302-019-09658-1
3
Amit Gulati, Aparna Tiwari, Vijay Shetty, Ifeanyi Nwosu, Sakshi Khurana. Tirofiban: A Rare Cause of Thrombocytopenia in a Patient Undergoing Percutaneous Coronary InterventionCureus 2021;  doi: 10.7759/cureus.18217
4
Usnish Adhikari, Krishna Kumar Mohanan Nair. Severe Thrombocytopenia after PCI: Think GP IIb/IIIa Receptor Antagonist Induced rather than Heparin-induced ThrombocytopeniaIndian Journal of Clinical Cardiology 2023; 4(4): 283 doi: 10.1177/26324636231213452
5
Michele Schiariti, Patrizia Saladini, Domenico Cuturello, Loredana Iannetta, Concetta Torromeo, Paolo Emilio Puddu. Decline in platelet count and long-term post-PCI ischemic events: Implication of the intra-aortic balloon pumpVascular Pharmacology 2014; 60(1): 25 doi: 10.1016/j.vph.2013.11.002
6
Mustafa Yurtdaş, Yalin Tolga Yaylali, Nesim Aladağ, Mahmut Özdemir, Memiş Hilmi Atay. Acute Serious Thrombocytopenia Associated with Intracoronary Tirofiban Use for Primary AngioplastyCase Reports in Medicine 2014; 2014: 1 doi: 10.1155/2014/190149
7
Zainab A. Almardod, Kishore G. Sam, Eman E. Younis, Quincy K Tran. Prevalence, Risk Factors, Characteristics, and Clinical Outcomes of Thrombocytopenia in the Intensive Care Unit: A Prospective Single‐Center Cohort StudyCritical Care Research and Practice 2026; 2026(1) doi: 10.1155/ccrp/4492230
8
Predrag Sikiric, Ivan Barisic, Mario Udovicic, Martina Lovric Bencic, Diana Balenovic, Dean Strinic, Gordana Zivanovic Posilovic, Sandra Uzun, Hrvoje Vranes, Ivan Krezic, Marin Lozic, Vasilije Stambolija, Ivica Premuzic Mestrovic, Lidija Beketic Oreskovic, Luka Kalogjera, Sanja Strbe, Suncana Sikiric, Laura Tomic, Mirjana Stupnisek, Mario Kordic, Ante Tvrdeic, Sven Seiwerth, Alenka Boban Blagaic, Anita Skrtic. Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related TherapeuticsPharmaceuticals 2026; 19(3): 463 doi: 10.3390/ph19030463
9
Khalil Kamar, Kira MacDougall, Mira Alsheikh, Sara Parylo, Yevgeniy Skaradinskiy. A rare case of eptifibatide-induced thrombocytopeniaJournal of Community Hospital Internal Medicine Perspectives 2021; 11(2): 269 doi: 10.1080/20009666.2021.1871802
10
Morteza Safi, Roozbeh Nazari, Nahid Senobari, Homa Taheri, Pouya Ebrahimi. A woman with eptifibatide (integrilin)‐induced thrombocytopenia following treatment of a clot in her coronary artery: A case report and literature reviewClinical Case Reports 2024; 12(4) doi: 10.1002/ccr3.8694
11
Łukasz Piątek, Agnieszka Janion-Sadowska, Jacek Kurzawski, Urszula Grabowska, Marianna Janion. Delayed severe abciximab-induced thrombocytopenia: A case reportHeart & Lung 2016; 45(5): 464 doi: 10.1016/j.hrtlng.2016.06.003